In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

Electronic Transmission of Claims

As contractors will be aware, as stated in the Drug Tariff to receive the recurring connectivity payment of £200pcm as of 31 March 2018 they were required to have a system compliant with Phase 2 releases 1,2 and 3 (which includes the Electronic Transmission of Claims (ETC) service).

As of 1 April 2019 the Drug Tariff will also include the following requirements:

“From June 2019, compliance with phase 2, release 3 will be assessed against the percentage of ETC claim messages submitted for qualifying prescription items. Qualifying items are defined as those prescribed on a WP10 prescription containing a 2DRx barcode. In order to retain the IM&T allowance, each contractor must submit ETC claim messages to meet the following thresholds:
Date Qualifying items in monthly account
From 1 June 2019 40%
From 1 September 2019 55%
From 1 December 2019 70%
From 1 March 2020 80%

NWSSP will shortly be commencing development work to add information to the NECAF home page in relation to targets such as ETC. In the interim period before this information goes live NWSSP will generate a monthly report for CPW containing the data for all 716 pharmacies which will contact a rolling 3 month position for ETC submissions. The first 2 months will show a percentage but the latest month will only show the ETC submission figures because, of course, the paper forms are yet to be received.  So, for example, March’s report will show: -
Pharmacy Dispensing Month ETC Submissions Valid 2DRx Forms Percentage ETC
A Pharmacy January 2019 n1 n3 n1%
A Pharmacy February 2019 n2 n4 n2%
A Pharmacy March 2019 n3 -- --

The first report has been received today by CPW;  contractors who would like to know what their current submission rates are, are asked to email stating their pharmacy name, address and account number